Thomas Ryan - PJT Partners Lead Independent Director
| PJT Stock | USD 166.85 4.06 2.49% |
Director
Mr. Thomas M. Ryan is an Independent Director of the Company. Mr. Ryan is the former Chairman and Chief Executive Officer of CVS Health Corporationrationration, formerly known as CVS Caremark Corporationrationration, a pharmacy healthcare provider. He served as Chairman from April 1999 to May 2011. He was Chief Executive Officer of CVS from May 1998 to February 2011 and also served as President from May 1998 to May 2010. Mr. Ryan serves on the board of Five Below, Inc., and is an Operating Partner of Advent International since 2022.
| Age | 68 |
| Tenure | 2 years |
| Address | 280 Park Avenue, New York, NY, United States, 10017 |
| Phone | 212 364 7800 |
| Web | https://www.pjtpartners.com |
Thomas Ryan Latest Insider Activity
Tracking and analyzing the buying and selling activities of Thomas Ryan against PJT Partners stock is an integral part of due diligence when investing in PJT Partners. Thomas Ryan insider activity provides valuable insight into whether PJT Partners is net buyers or sellers over its current business cycle. Note, PJT Partners insiders must abide by specific rules, including filing SEC forms every time they buy or sell PJT Partners'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Thomas Ryan few days ago Disposition of 50000 shares by Thomas Ryan of Service International at 37.53 subject to Rule 16b-3 | ||
Thomas Ryan over three months ago Disposition of 74189 shares by Thomas Ryan of Service International at 29.25 subject to Rule 16b-3 | ||
Thomas Ryan over three months ago Disposition of 4215 shares by Thomas Ryan of Service International at 29.25 subject to Rule 16b-3 | ||
Thomas Ryan over three months ago Disposition of 16362 shares by Thomas Ryan of Service International at 29.25 subject to Rule 16b-3 |
PJT Partners Management Efficiency
The company has Return on Asset of 0.1401 % which means that on every $100 spent on assets, it made $0.1401 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2281 %, implying that it generated $0.2281 on every 100 dollars invested. PJT Partners' management efficiency ratios could be used to measure how well PJT Partners manages its routine affairs as well as how well it operates its assets and liabilities. At this time, PJT Partners' Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 0.46 in 2024, whereas Return On Tangible Assets are likely to drop 0.05 in 2024. Total Current Liabilities is likely to drop to about 45.8 M in 2024. Liabilities And Stockholders Equity is likely to drop to about 855.4 M in 2024Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Adam Berlew | Stifel Financial | 53 | |
| Simon Robertson | Evercore Partners | 79 | |
| William Ehrhardt | Oppenheimer Holdings | 77 | |
| Todd Esq | Houlihan Lokey | 61 | |
| Jeffrey Werbalowsky | Houlihan Lokey | N/A | |
| James Oates | Stifel Financial | 74 | |
| Barry Alperin | Jefferies Financial Group | 79 | |
| MaryAnne Gilmartin | Jefferies Financial Group | 56 | |
| Steven Heyer | Lazard | 66 | |
| Andrew Alper | Lazard | 62 | |
| Jacqueline Kosecoff | Houlihan Lokey | 71 | |
| Philip Laskawy | Lazard | 79 | |
| Gail Harris | Evercore Partners | 67 | |
| Paul Friedman | Oppenheimer Holdings | 65 | |
| Kathleen Brown | Stifel Financial | 74 | |
| Iris Knobloch | Lazard | 57 | |
| Sylvia Jay | Lazard | 73 | |
| Michelle Jarrard | Lazard | 52 | |
| Yolonda Richardson | Moelis Co | 58 | |
| Michael Brown | Stifel Financial | 74 | |
| Jane Mendillo | Lazard | 61 | |
Management Performance
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.14 |
PJT Partners Leadership Team
Elected by the shareholders, the PJT Partners' board of directors comprises two types of representatives: PJT Partners inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PJT. The board's role is to monitor PJT Partners' management team and ensure that shareholders' interests are well served. PJT Partners' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PJT Partners' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Ryan, Lead Independent Director | ||
| MBA BS, Chairman Partner | ||
| Dennis Hersch, Lead Independent Director | ||
| Karl Knapp, Partner Group | ||
| Steven Murray, Partner Officer | ||
| Lyssa Dubensky, President | ||
| David Travin, Deputy General Counsel | ||
| Adam Schlesinger, Managing Director | ||
| Paige Costigan, Chief Officer | ||
| Grace Skaugen, Independent Director | ||
| Helen Meates, Chief Financial Officer | ||
| Emily Rafferty, Independent Director | ||
| Kenneth Whitney, Independent Director | ||
| James Costos, Independent Director | ||
| James Cuminale, General Counsel | ||
| Tom Campbell, Partner Group | ||
| Nick Tansley, MD Industrials | ||
| Paul Taubman, Chairman of The Board, CEO and Chairman of Nominating/Corporate Governance Committee | ||
| Sharon Pearson, MD Relations | ||
| JiYeun Lee, Managing Partner |
PJT Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PJT Partners a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.14 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 4.16 B | ||||
| Shares Outstanding | 23.7 M | ||||
| Shares Owned By Insiders | 7.45 % | ||||
| Shares Owned By Institutions | 86.27 % | ||||
| Number Of Shares Shorted | 1.26 M | ||||
| Price To Earning | 16.44 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PJT Stock Analysis
When running PJT Partners' price analysis, check to measure PJT Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PJT Partners is operating at the current time. Most of PJT Partners' value examination focuses on studying past and present price action to predict the probability of PJT Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PJT Partners' price. Additionally, you may evaluate how the addition of PJT Partners to your portfolios can decrease your overall portfolio volatility.